|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$653M
|
-$112M
|
-3,310,708
|
-16%
|
|
|
2
|
Franklin Resources
San Mateo,
California
|
$356M
|
+$12.9M
|
+382,532
|
+4%
|
|
|
3
|
Janus Henderson Investors US
Denver,
Colorado
|
$347M
|
+$3.92M
|
+116,232
|
+1%
|
|
|
4
|
Vanguard Group
Malvern,
Pennsylvania
|
$339M
|
-$10.9M
|
-323,492
|
-4%
|
|
|
5
|
Adage Capital Partners
Boston,
Massachusetts
|
$306M
|
-$46.5M
|
-1,380,000
|
-15%
|
|
|
6
|
William Blair & Company
Chicago,
Illinois
|
$190M
|
+$621K
|
+18,408
|
+0.4%
|
|
|
7
|
|
$189M
|
-$18.7M
|
-555,000
|
-10%
|
|
|
8
|
Knoll Capital Management
Miami,
Florida
|
$176M
|
–
|
–
|
–
|
|
|
9
|
Wellington Management Group
Boston,
Massachusetts
|
$156M
|
-$15.9M
|
-470,710
|
-10%
|
|
|
10
|
BlackRock Institutional Trust
San Francisco,
California
|
$144M
|
-$791K
|
-23,454
|
-0.6%
|
|
|
11
|
|
$135M
|
+$17.3M
|
+511,796
|
+17%
|
|
|
12
|
Wells Fargo
San Francisco,
California
|
$134M
|
-$36.4M
|
-1,080,202
|
-24%
|
|
|
13
|
Bain Capital Public Equity Management
Boston,
Massachusetts
|
$122M
|
+$11.6M
|
+342,600
|
+12%
|
|
|
14
|
PFM Health Sciences
San Francisco,
California
|
$117M
|
+$85.2M
|
+2,526,624
|
+495%
|
|
|
15
|
BB Biotech
Schaffhausen,
Switzerland
|
$116M
|
+$2.7M
|
+80,000
|
+3%
|
|
|
16
|
BlackRock Fund Advisors
San Francisco,
California
|
$114M
|
-$2.02M
|
-59,820
|
-2%
|
|
|
17
|
|
$104M
|
+$42.9M
|
+1,272,166
|
+89%
|
|
|
18
|
Lord, Abbett & Co
Jersey City,
New Jersey
|
$102M
|
-$33M
|
-977,782
|
-27%
|
|
|
19
|
Waddell & Reed Financial
Overland Park,
Kansas
|
$98.1M
|
+$350K
|
+10,376
|
+0.4%
|
|
|
20
|
HealthCor Management
New York
|
$82.9M
|
+$5.06M
|
+150,000
|
+8%
|
|
|
21
|
State Street
Boston,
Massachusetts
|
$82.5M
|
-$5.08M
|
-150,664
|
-7%
|
|
|
22
|
Columbus Circle Investors
|
$81.6M
|
-$29.9M
|
-885,570
|
-29%
|
|
|
23
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$71.7M
|
-$8.8M
|
-261,104
|
-12%
|
|
|
24
|
OppenheimerFunds
New York
|
$70.3M
|
+$1.49M
|
+44,180
|
+2%
|
|
|
25
|
|
$68.6M
|
-$372K
|
-11,018
|
-0.6%
|
|
